| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| JAZZ | JAZZ PHARMACEUTICALS PLC | $13.32B | 62,742,820 | 28.79% | 71.21% | Net Selling | Net Selling | ||
| INVA | INNOVIVA INC | $1.68B | 74,073,646 | 60.21% | 39.79% | Net Buying | Net Selling | ||
| VCYT | VERACYTE INC | $2.62B | 79,458,427 | 66.85% | 33.15% | Net Selling | Net Selling | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $373.94M | 50,876,487 | 61.74% | 38.26% | Net Selling | |||
| ANAB | ANAPTYSBIO INC | $1.99B | 28,748,255 | 40.80% | 59.20% | Net Selling | Net Selling | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.13B | 132,970,979 | 54.35% | 13.23% | Net Buying | Net Buying | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $2.26B | 250,800,620 | 83.18% | 15.30% | Net Selling | Net Buying | ||
| SPRO | SPERO THERAPEUTICS INC | $140.10M | 57,891,493 | 36.48% | 62.44% | Net Selling | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $4.37B | 76,938,016 | 55.85% | 9.27% | Net Selling | Net Selling | ||
| ASMB | ASSEMBLY BIOSCIENCES INC | $468.74M | 15,862,705 | 52.43% | 47.57% | Net Selling | Net Selling | ||
| PHAR | PHARMING GROUP NV | $1.13B | 701,680,440 | 0.02% | 0.00% | ||||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.07B | 172,431,290 | 58.47% | 14.30% | Net Selling | Net Buying | ||
| CUE | CUE BIOPHARMA INC | $113.74M | 3,255,360 | 78.46% | 21.54% | Net Buying | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $40.20B | 133,512,573 | 82.35% | 17.65% | Net Selling | Net Selling | ||
| TBPH | THERAVANCE BIOPHARMA INC | $861.48M | 51,492,924 | 53.54% | 46.46% | Net Selling | Net Selling | ||
| REGN | REGENERON PHARMACEUTICALS INC | $73.63B | 104,839,032 | 68.82% | 31.18% | Net Selling | Net Selling | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $107.70B | 253,805,417 | 92.90% | 1.52% | Net Selling | Net Selling | ||
| AGEN | AGENUS INC | $160.12M | 38,398,354 | 7.15% | 92.85% | Net Buying | Net Buying | ||
| KRYS | KRYSTAL BIOTECH INC | $8.39B | 29,479,756 | 80.01% | 19.99% | Net Selling | Net Selling | ||
| STTK | SHATTUCK LABS INC | $468.03M | 71,564,217 | 58.73% | 20.75% | Net Buying | |||
| EXEL | EXELIXIS INC | $11.17B | 251,355,083 | 94.72% | 5.28% | Net Selling | Net Selling | ||
| ONC | BEONE MEDICINES LTD | $33.04B | 1,442,259,810 | 2.35% | 32.03% | Net Buying | Net Buying | ||
| CGEN | COMPUGEN LTD | $257.18M | 94,553,191 | 13.32% | 0.32% | Net Buying | Net Buying | ||
| GLPG | GALAPAGOS NV | $1.87B | 65,897,071 | 47.64% | 0.00% | ||||
| INCY | INCYTE CORP | $19.47B | 199,782,155 | 77.92% | 22.08% | Net Selling | Net Selling | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $2.90B | 124,033,382 | 77.21% | 22.79% | Net Selling | Net Selling | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.77B | 122,123,884 | 84.18% | 15.82% | Net Selling | |||
| SLGL | SOL-GEL TECHNOLOGIES LTD | $205.53M | 2,786,158 | 24.11% | 75.89% | Net Buying | Net Buying | ||
| XLO | XILIO THERAPEUTICS INC | $44.58M | 5,782,511 | 53.31% | 46.69% | Net Buying | Net Buying | ||
| VCEL | VERICEL CORP | $1.87B | 50,763,319 | 91.10% | 8.90% | Net Selling | Net Selling | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $622.93M | 58,711,584 | 64.97% | 21.95% | Net Selling | Net Buying | ||
| RPRX | ROYALTY PHARMA PLC | $29.10B | 576,856,753 | 61.89% | 17.26% | Net Selling | Net Selling | ||
| LQDA | LIQUIDIA CORP | $3.54B | 88,114,429 | 50.08% | 49.92% | Net Selling | Net Selling | ||
| ADMA | ADMA BIOLOGICS INC | $2.44B | 238,159,176 | 79.68% | 20.32% | Net Selling | Net Selling | ||
| MGTX | MEIRAGTX HOLDINGS PLC | $794.10M | 81,446,126 | 57.44% | 42.56% | Net Selling | Net Buying | ||
| CDXS | CODEXIS INC | $249.89M | 90,869,349 | 46.64% | 53.36% | Net Selling | Net Selling | ||
| TVTX | TRAVERE THERAPEUTICS INC | $4.17B | 92,992,905 | 63.78% | 36.22% | Net Selling | Net Selling | ||
| NAGE | NIAGEN BIOSCIENCE INC | $385.99M | 80,080,488 | 18.62% | 81.38% | Net Buying | Net Buying | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.29B | 193,284,438 | 97.36% | 1.78% | Net Selling | Net Selling | ||
| ENTA | ENANTA PHARMACEUTICALS INC | $420.20M | 29,019,344 | 64.96% | 35.04% | Net Selling | Net Selling | ||
| HALO | HALOZYME THERAPEUTICS INC | $7.77B | 118,017,000 | 78.05% | 21.95% | Net Selling | Net Selling | ||
| TARS | TARSUS PHARMACEUTICALS INC | $2.77B | 42,557,492 | 72.94% | 27.06% | Net Selling | Net Selling | ||
| DTIL | PRECISION BIOSCIENCES INC | $192.23M | 25,802,247 | 35.28% | 64.72% | Net Selling | Net Selling | ||
| LGND | LIGAND PHARMACEUTICALS INC | $4.63B | 19,941,141 | 18.32% | 81.68% | Net Selling | Net Selling | ||
| ORMP | ORAMED PHARMACEUTICALS INC | $160.98M | 40,446,179 | 27.33% | 55.88% | Net Selling | Net Selling | ||
| LCTX | LINEAGE CELL THERAPEUTICS INC | $363.67M | 249,087,529 | 39.96% | 60.04% | Net Selling | Net Selling | ||
| IBRX | IMMUNITYBIO INC | $7.79B | 1,028,111,456 | 16.47% | 7.45% | Net Buying | Net Buying | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $96.28M | 89,979,619 | 9.59% | 56.99% | Net Selling | Net Selling | ||
| UTHR | UNITED THERAPEUTICS CORP | $25.08B | 43,827,686 | 86.81% | 13.19% | Net Selling | Net Selling | ||
| ARGX | ARGENX SE | $49.18B | 61,883,306 | 48.47% | 0.00% | ||||
| TECH | BIO-TECHNE CORP | $8.87B | 156,453,292 | 97.77% | 2.23% | Net Selling | Net Selling | ||
| NRXP | NRX PHARMACEUTICALS INC | $100.53M | 33,067,630 | 9.51% | 90.49% | ||||
| VIR | VIR BIOTECHNOLOGY INC | $1.40B | 139,517,278 | 69.12% | 30.88% | Net Selling | Net Selling | ||
| TSHA | TAYSHA GENE THERAPIES INC | $1.99B | 287,269,885 | 89.47% | 10.53% | Net Selling | Net Selling | ||
| OMER | OMEROS CORP | $1.06B | 71,996,171 | 47.11% | 5.03% | Net Buying | Net Buying | ||
| VRCA | VERRICA PHARMACEUTICALS INC | $123.00M | 17,178,786 | 15.89% | 84.11% | Net Buying | |||
| INSM | INSMED INC | $30.06B | 215,551,896 | 84.92% | 15.08% | Net Selling | Net Selling | ||
| ASND | ASCENDIS PHARMA A | $13.83B | 61,380,312 | 99.19% | 0.81% | ||||
| NUVB | NUVATION BIO INC | $1.69B | 349,201,971 | 57.01% | 42.99% | Net Buying | Net Buying | ||
| KYMR | KYMERA THERAPEUTICS INC | $6.80B | 82,257,588 | 77.04% | 22.96% | Net Buying | Net Selling | ||
| FENC | FENNEC PHARMACEUTICALS INC | $231.67M | 34,475,178 | 4.33% | 95.67% | Net Selling | Net Buying | ||
| PRTA | PROTHENA CORP PUBLIC LTD CO | $602.39M | 53,832,982 | 52.43% | 47.57% | ||||
| ABUS | ARBUTUS BIOPHARMA CORP | $860.10M | 195,478,068 | 30.49% | 69.51% | ||||
| QTTB | Q32 BIO INC | $87.16M | 16,956,415 | 28.18% | 71.82% | Net Selling | Net Selling | ||
| MIRM | MIRUM PHARMACEUTICALS INC | $6.38B | 60,341,617 | 53.72% | 46.28% | Net Buying | Net Selling | ||
| OBIO | ORCHESTRA BIOMED HOLDINGS INC | $234.67M | 58,520,901 | 35.29% | 64.71% | Net Buying | Net Selling | ||
| CBIO | CRESCENT BIOPHARMA INC | $498.50M | 27,571,935 | 24.78% | 75.22% | Net Buying | |||
| PTGX | PROTAGONIST THERAPEUTICS INC | $6.33B | 63,808,716 | 82.89% | 17.11% | Net Selling | Net Selling | ||
| PLYX | POLARYX THERAPEUTICS INC | $214.94M | 47,343,297 | 0.00% | 52.80% | Net Buying | Net Buying | ||
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | $989.71M | 257,067,242 | 45.21% | 54.79% | Net Buying | Net Selling | ||
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $2.12B | 153,981,561 | 63.04% | 36.96% | Net Selling | Net Selling | ||
| OVID | OVID THERAPEUTICS INC | $373.21M | 131,874,634 | 46.85% | 14.10% | Net Buying | Net Buying | ||
| ARDX | ARDELYX INC | $1.76B | 247,029,387 | 42.17% | 57.83% | Net Buying | Net Buying | ||
| SLN | SILENCE THERAPEUTICS PLC | $336.91M | 141,701,848 | 12.77% | 0.09% | ||||
| LEGN | LEGEND BIOTECH CORP | $5.27B | 369,886,369 | 23.68% | 0.15% | Net Selling | Net Selling | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $10.49B | 140,032,190 | 82.92% | 9.83% | Net Selling | Net Selling | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.87B | 57,840,614 | 77.07% | 22.93% | Net Selling | Net Selling | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $3.81B | 170,494,613 | 72.02% | 27.98% | Net Selling | Net Selling | ||
| ALMS | ALUMIS INC | $3.32B | 127,199,333 | 62.16% | 23.09% | Net Buying | |||
| KZIA | KAZIA THERAPEUTICS LTD | $762.35M | 5,667,995,734 | 0.04% | 0.39% | ||||
| ADAG | ADAGENE INC | $171.54M | 59,231,993 | 5.22% | 1.43% | ||||
| ANL | ADLAI NORTYE LTD | $596.61M | 120,000,803 | 0.05% | 0.00% | ||||
| BEAM | BEAM THERAPEUTICS INC | $2.94B | 101,856,245 | 86.28% | 13.72% | Net Selling | Net Selling | ||
| MANE | VERADERMICS INC | $4.29B | 37,340,290 | 0.00% | 16.86% | Net Buying | |||
| RLYB | RALLYBIO CORP | $75.54M | 5,289,675 | 38.31% | 61.69% | Net Selling | Net Selling | ||
| SEPN | SEPTERNA INC | $1.08B | 44,906,374 | 66.75% | 33.25% | Net Buying | Net Buying | ||
| MESO | MESOBLAST LTD | $2.03B | 1,288,514,948 | 0.33% | 19.20% | Net Buying | Net Buying | ||
| AKTS | AKTIS ONCOLOGY INC | $1.04B | 53,403,173 | 0.00% | 59.96% | Net Buying | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $34.66M | 1,340,281 | 0.43% | 99.57% | Net Selling | |||
| FTRE | FORTREA HOLDINGS INC | $1.37B | 94,600,000 | 99.43% | 0.57% | Net Buying | Net Selling | ||
| CCCC | C4 THERAPEUTICS INC | $289.81M | 97,578,175 | 79.95% | 20.05% | Net Selling | Net Selling | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $529.00M | 243,777,920 | 66.72% | 31.96% | Net Selling | Net Selling | ||
| KLRS | KALARIS THERAPEUTICS INC | $121.52M | 22,928,303 | 5.69% | 94.31% | Net Buying | Net Selling | ||
| TGTX | TG THERAPEUTICS INC | $5.76B | 159,688,256 | 58.07% | 41.93% | Net Selling | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $157.92M | 80,571,642 | 9.84% | 90.16% | Net Buying | |||
| RIGL | RIGEL PHARMACEUTICALS INC | $518.91M | 18,473,130 | 39.34% | 60.66% | Net Selling | Net Selling | ||
| AKBA | AKEBIA THERAPEUTICS INC | $388.42M | 267,879,239 | 44.14% | 8.15% | Net Selling | Net Buying | ||
| NRXS | NEURAXIS INC | $97.22M | 11,187,639 | 14.06% | 34.69% | Net Buying | Net Buying | ||
| ACIU | AC IMMUNE SA | $306.24M | 101,742,231 | 25.33% | 4.32% | Net Buying | Net Buying | ||
| HYPD | HYPERION DEFI INC | $53.20M | 11,391,645 | 5.48% | 94.52% | Net Buying |